WASHINGTON (Reuters) -The U.S. Supreme Court on Monday declined to hear a bid by Sanofi SA to revive its antitrust lawsuit accusing rival pharmaceutical company Viatris Inc of illegally monopolizing ...
Sanofi claimed Viatris (formerly Mylan) used rebates to pharmacy benefit managers to secure monopoly A 10th Circuit panel said negotiating exclusivity for lower consumer prices was legal (Reuters) - ...
WASHINGTON, April 17 (Reuters) - The U.S. Supreme Court on Monday declined to hear a bid by Sanofi SA (SASY.PA), opens new tab to revive its antitrust lawsuit accusing rival pharmaceutical company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback